Inflammation Causes Resistance to Anti-CD20-Mediated B Cell Depletion.

about

Current status of alloimmunity.Use of polyclonal/monoclonal antibody therapies in transplantation.Plasma cell survival in the absence of B cell memory.

P2860

Q34047345-BCC8A66A-5341-4870-9CD5-7DD45E5B5AAC Q38769922-CE464482-2C8F-4FE9-A34B-99175A608626 Q47113778-460679C7-B3D5-4DE8-9147-0A581C148B9F

P2860

Inflammation Causes Resistance to Anti-CD20-Mediated B Cell Depletion.

Item

http://www.wikidata.org/entity/Q39708039

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Inflammation Causes Resistance to Anti-CD20-Mediated B Cell Depletion.

@en

Inflammation Causes Resistance to Anti-CD20-Mediated B Cell Depletion.

@nl

type

Item

label

Inflammation Causes Resistance to Anti-CD20-Mediated B Cell Depletion.

@en

Inflammation Causes Resistance to Anti-CD20-Mediated B Cell Depletion.

@nl

prefLabel

Inflammation Causes Resistance to Anti-CD20-Mediated B Cell Depletion.

@en

Inflammation Causes Resistance to Anti-CD20-Mediated B Cell Depletion.

@nl

P1476

Inflammation Causes Resistance to Anti-CD20-Mediated B Cell Depletion.

@en

P2093

A Waisman

http://www.w3.org/2001/XMLSchema#string

C E Parker

http://www.w3.org/2001/XMLSchema#string

G Cherala

http://www.w3.org/2001/XMLSchema#string

J S Obhrai

http://www.w3.org/2001/XMLSchema#string

L H Laws

http://www.w3.org/2001/XMLSchema#string

L V Riella

http://www.w3.org/2001/XMLSchema#string

M K Slifka

http://www.w3.org/2001/XMLSchema#string

M Y Yeung

http://www.w3.org/2001/XMLSchema#string

Y Koguchi

http://www.w3.org/2001/XMLSchema#string

P2860

Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics

TIM-1 signaling is required for maintenance and induction of regulatory B cells.

Neonatal Fc receptor and IgG-based therapeutics

Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys.

Preclinical and phase I and II trials of rituximab.

Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus.

B-cell-depleting induction therapy and acute cellular rejection

Recipient B cells are not required for graft-versus-host disease induction.

Antibody effector functions mediated by Fcγ-receptors are compromised during persistent viral infection.

Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice.

P304

3139-3149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJT.13902

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martin H Oberbarnscheidt

P577

2016-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27265023

http://www.w3.org/2001/XMLSchema#string

P921

inflammation

P932

5334788

http://www.w3.org/2001/XMLSchema#string

Inflammation Causes Resistance to Anti-CD20-Mediated B Cell Depletion.

about

P2860

P2860

Inflammation Causes Resistance to Anti-CD20-Mediated B Cell Depletion.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932